Insider Transactions in Q4 2023 at Madrigal Pharmaceuticals, Inc. (MDGL)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 15
2023
|
Robert E. Waltermire Senior VP, Chief Pharma Dev. |
SELL
Open market or private sale
|
Direct |
2,000
-14.02%
|
$476,000
$238.5 P/Share
|
|
Dec 15
2023
|
Robert E. Waltermire Senior VP, Chief Pharma Dev. |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+20.69%
|
$174,000
$87.92 P/Share
|
|
Dec 14
2023
|
Robert E. Waltermire Senior VP, Chief Pharma Dev. |
SELL
Open market or private sale
|
Direct |
2,000
-14.02%
|
$464,000
$232.5 P/Share
|
|
Dec 14
2023
|
Robert E. Waltermire Senior VP, Chief Pharma Dev. |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+20.69%
|
$174,000
$87.92 P/Share
|
|
Dec 14
2023
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
20,633
+0.24%
|
$4,704,324
$228.37 P/Share
|
|
Dec 13
2023
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
81,159
+0.47%
|
$17,854,980
$220.73 P/Share
|
|
Dec 13
2023
|
Robert E. Waltermire Senior VP, Chief Pharma Dev. |
SELL
Open market or private sale
|
Direct |
2,500
-16.68%
|
$562,500
$225.5 P/Share
|
|
Dec 13
2023
|
Robert E. Waltermire Senior VP, Chief Pharma Dev. |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+23.44%
|
$217,500
$87.92 P/Share
|
|
Dec 12
2023
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
34,578
+0.11%
|
$7,365,114
$213.61 P/Share
|
|
Dec 12
2023
|
Robert E. Waltermire Senior VP, Chief Pharma Dev. |
SELL
Open market or private sale
|
Direct |
1,300
-9.77%
|
$282,100
$217.5 P/Share
|
|
Dec 12
2023
|
Robert E. Waltermire Senior VP, Chief Pharma Dev. |
BUY
Exercise of conversion of derivative security
|
Direct |
1,300
+15.73%
|
$113,100
$87.92 P/Share
|
|
Dec 07
2023
|
Fred B Craves Director |
SELL
Other acquisition or disposition
|
Indirect |
1,556,594
-98.67%
|
-
|
|
Dec 05
2023
|
Brian Joseph Lynch SVP and General Counsel |
SELL
Open market or private sale
|
Direct |
1,000
-6.25%
|
$227,000
$227.33 P/Share
|
|
Dec 05
2023
|
Brian Joseph Lynch SVP and General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+5.88%
|
$87,000
$87.09 P/Share
|
|
Dec 04
2023
|
Brian Joseph Lynch SVP and General Counsel |
SELL
Open market or private sale
|
Direct |
1,800
-5.51%
|
$392,400
$218.56 P/Share
|
|
Dec 04
2023
|
Brian Joseph Lynch SVP and General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
1,800
+5.22%
|
$144,000
$80.42 P/Share
|
|
Nov 30
2023
|
Brian Joseph Lynch SVP and General Counsel |
SELL
Open market or private sale
|
Direct |
3,000
-5.9%
|
$612,000
$204.58 P/Share
|
|
Nov 30
2023
|
Brian Joseph Lynch SVP and General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+14.29%
|
$219,000
$73.75 P/Share
|
|
Nov 29
2023
|
Brian Joseph Lynch SVP and General Counsel |
SELL
Open market or private sale
|
Direct |
4,000
-10.96%
|
$792,000
$198.92 P/Share
|
|
Nov 29
2023
|
Brian Joseph Lynch SVP and General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+17.39%
|
$292,000
$73.75 P/Share
|
|
Nov 21
2023
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
64,350
+0.32%
|
$12,033,450
$187.21 P/Share
|
|
Nov 20
2023
|
Carole Huntsman Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,834
+50.0%
|
-
|
|
Nov 20
2023
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
20,709
+0.18%
|
$3,851,874
$186.18 P/Share
|
|
Nov 17
2023
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
46,370
+0.27%
|
$7,975,640
$172.91 P/Share
|
|
Nov 15
2023
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
15,199
+0.8%
|
$2,447,039
$161.97 P/Share
|
|
Nov 14
2023
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
71,848
+0.55%
|
$10,992,744
$153.96 P/Share
|
|
Nov 13
2023
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
69,839
+0.44%
|
$9,847,299
$141.51 P/Share
|